Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger B Cohen

Showing results (11-20 of 208) with videos related to

Pageof 21
Sort By:
Current Oncology Reports|April 2, 2008
EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neckRanee Mehra, Roger B Cohen, Paul M Harari
Biologics : Targets & Therapy|August 18, 2010
The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancerMohamedtaki A Tejani, Roger B Cohen, Ranee Mehra
Current Cancer Drug Targets|December 16, 2006
EGFR-targeting monoclonal antibodies in head and neck cancerIgor Astsaturov, Roger B Cohen, Paul M Harari
Translational Lung Cancer Research|May 23, 2017
Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumorsSuchit H Patel, Andreas Rimner, Roger B Cohen
Therapeutic Advances in Medical Oncology|May 31, 2016
Immunotherapy for head and neck cancer: latest developments and clinical potentialJoshua M Bauml, Roger B Cohen, Charu Aggarwal
Annals of Translational Medicine|October 3, 2019
Immunotherapy for head and neck cancer: where are we now and where are we going?Joshua M Bauml, Charu Aggarwal, Roger B Cohen
Cancer Treatment and Research|February 2, 2008
Clinical application of EGFR inhibitors in head and neck squamous cell cancerIgor Astsaturov, Roger B Cohen, Paul M Harari
Clinical Advances in Hematology & Oncology : H&O|November 11, 2008
The role of cetuximab for the treatment of squamous cell carcinoma of the head and neckRanee Mehra, Roger B Cohen, Barbara A Burtness
Oral Oncology|August 19, 2024
Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC)Lova Sun, Roger B Cohen, A Dimitrios Colevas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2005
Targeting signal transduction pathways in colorectal cancer--more than skin deepSteven J Cohen, Roger B Cohen, Neal J Meropol
Pageof 21

Showing results (11-20 of 208) with videos related to

Sort By:
Pageof 21
Current Oncology Reports|April 2, 2008
EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neckRanee Mehra, Roger B Cohen, Paul M Harari
Biologics : Targets & Therapy|August 18, 2010
The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancerMohamedtaki A Tejani, Roger B Cohen, Ranee Mehra
Current Cancer Drug Targets|December 16, 2006
EGFR-targeting monoclonal antibodies in head and neck cancerIgor Astsaturov, Roger B Cohen, Paul M Harari
Translational Lung Cancer Research|May 23, 2017
Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumorsSuchit H Patel, Andreas Rimner, Roger B Cohen
Therapeutic Advances in Medical Oncology|May 31, 2016
Immunotherapy for head and neck cancer: latest developments and clinical potentialJoshua M Bauml, Roger B Cohen, Charu Aggarwal
Annals of Translational Medicine|October 3, 2019
Immunotherapy for head and neck cancer: where are we now and where are we going?Joshua M Bauml, Charu Aggarwal, Roger B Cohen
Cancer Treatment and Research|February 2, 2008
Clinical application of EGFR inhibitors in head and neck squamous cell cancerIgor Astsaturov, Roger B Cohen, Paul M Harari
Clinical Advances in Hematology & Oncology : H&O|November 11, 2008
The role of cetuximab for the treatment of squamous cell carcinoma of the head and neckRanee Mehra, Roger B Cohen, Barbara A Burtness
Oral Oncology|August 19, 2024
Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC)Lova Sun, Roger B Cohen, A Dimitrios Colevas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2005
Targeting signal transduction pathways in colorectal cancer--more than skin deepSteven J Cohen, Roger B Cohen, Neal J Meropol
Pageof 21